PRESS RELEASE published on 09/05/2023 at 17:45, 2 years 6 months ago Lepermislibre: Update of the 2023 financial communication calendar
PRESS RELEASE published on 07/05/2023 at 17:45, 2 years 8 months ago Lepermislibre: Q2 2023 revenue. 21% growth in business activity compared to Q2 2022. Increased brand recognition and launch of new offers.
PRESS RELEASE published on 04/06/2023 at 18:00, 2 years 11 months ago Lepermislibre: 2022 full-year results and Q1 2023 revenue
PRESS RELEASE published on 02/08/2023 at 19:07, 3 years 1 month ago Lepermislibre: Lepermislibre announces the success of its IPO on the Euronext Growth® market in Paris
PRESS RELEASE published on 01/25/2023 at 07:30, 3 years 1 month ago Lepermislibre: Lepermislibre announces the launch of its IPO on the Euronext Growth® market in Paris
Published on 03/16/2026 at 22:30, 8 hours 49 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 9 hours 19 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 9 hours 49 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 10 hours 19 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 07:05, 13 minutes ago Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
Published on 03/17/2026 at 07:03, 16 minutes ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 19 minutes ago PolyPeptide publishes invitation to the annual General Meeting 2026
Published on 03/17/2026 at 07:00, 19 minutes ago Very strong business performance delivered in 2025. Continued growth expected in 2026
Published on 03/17/2026 at 06:59, 19 minutes ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 19 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 13 hours 19 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 13 hours 21 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours 22 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
